Home / Import refusals / AEK-6367885-5/11/1

AEK-6367885-5/11/1

Janssen Pharmaceuticals Inc. — FEI 2211100

Recent inspections

  • 1225275 (VAI Thu Dec 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1175643 (NAI Fri Jun 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 998113 (NAI Thu Jan 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 965139 (NAI Fri Jan 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 833775 (NAI Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • AEK-8291214-6/11/1 (Fri Mar 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-8217128-9/11/1 (Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-8225342-6/11/1 (Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-8221486-5/11/1 (Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-8218885-3/11/1 (Fri Feb 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
October 1, 2019
Country
United States
Product Category
Drugs and Biologics
Product Code
61PAY69 CANAGLIFLOZIN (ANTI-DIABETIC)
Charges
75